ConductScience.org, home

Paper1712901

The immunosuppressant FK-506 specifically inhibits mitogen-induced activation of the interleukin-2 promoter and the isolated enhancer elements NFIL-2A and NF-AT1.

Banerji SS and 2 others. Mol Cell Biol, 1991. Cited by 49 papers, by iCite.

Cite this record

ConductScience Library. The immunosuppressant FK-506 specifically inhibits mitogen-induced activation of the interleukin-2 promoter and the isolated enhancer elements NFIL-2A and NF-AT1. Papers, record 1712901. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1712901

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The immunosuppressant FK-506 specifically inhibits mitogen-induced activation of the interleukin-2 promoter and the isolated enhancer elements NFIL-2A and NF-AT1.
PubMed
Journal
Mol Cell Biol
PubMed
Year
1991
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
49
iCite
Relative citation ratio, by iCite
1.15
iCite
Revised in PubMed
2021-05-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Banerji SSS S
2Parsons JNJ N
3Tocci MJM J

Source PubMed

Download CSV of authors

Topics23

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
Concanavalin AMajor topic
Enhancer Elements, GeneticMajor topic
Gene Expression RegulationMajor topic
Immunosuppressive AgentsMajor topic
Interleukin-2Major topic
Promoter Regions, GeneticMajor topic
Tetradecanoylphorbol AcetateMajor topic
Base Sequence
Cell Line
Cell Nucleus
Chloramphenicol O-Acetyltransferase
DNA-Binding Proteins
Humans
Ionomycin
Kinetics
Molecular Sequence Data
NF-kappa B
Oligonucleotide Probes
Regulatory Sequences, Nucleic Acid
Retroviridae
TATA Box
Tacrolimus

Source PubMed

Download CSV of topics

References70

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12556266The octamer-binding proteins form multi-protein--DNA complexes with the HSV alpha TIF regulatory protein.EMBO J1989https://conductscience.org/library/papers/2556266PubMed
22477715A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase.Nature1989https://conductscience.org/library/papers/2477715PubMed
32799385Interleukin-1 costimulatory activity on the interleukin-2 promoter via AP-1.Science1989https://conductscience.org/library/papers/2799385PubMed
43145412The NF-kappa B-binding site mediates phorbol ester-inducible transcription in nonlymphoid cells.Mol Cell Biol1988https://conductscience.org/library/papers/3145412PubMed
52492638Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins.Nature1989https://conductscience.org/library/papers/2492638PubMed
62644542Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin.Nature1989https://conductscience.org/library/papers/2644542PubMed
72838551Two regions within the human IL-2 gene promoter are important for inducible IL-2 expression.J Immunol1988https://conductscience.org/library/papers/2838551PubMed
83491296Promoter region of interleukin-2 gene undergoes chromatin structure changes and confers inducibility on chloramphenicol acetyltransferase gene during activation of T cells.Mol Cell Biol1986https://conductscience.org/library/papers/3491296PubMed
92830252Cyclosporin A inhibits late steps of T lymphocyte activation after transmembrane signaling.J Biochem1987https://conductscience.org/library/papers/2830252PubMed
102830495T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression.Mol Cell Biol1987https://conductscience.org/library/papers/2830495PubMed
112848811Nuclear factors interacting with the mitogen-responsive regulatory region of the interleukin-2 gene.J Biol Chem1988https://conductscience.org/library/papers/2848811PubMed
122843294Cooperativity and hierarchical levels of functional organization in the SV40 enhancer.Cell1988https://conductscience.org/library/papers/2843294PubMed
132842768A herpesvirus trans-activating protein interacts with transcription factor OTF-1 and other cellular proteins.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/2842768PubMed
143015413Regulation of human interleukin-2 gene: functional DNA sequences in the 5' flanking region for the gene expression in activated T lymphocytes.Cell1986https://conductscience.org/library/papers/3015413PubMed
153006925Sequence-specific interactions of nuclear factors with the insulin gene enhancer.Cell1986https://conductscience.org/library/papers/3006925PubMed
162966477Effects of cyclosporine A on T lymphocytes and accessory cells from human blood.Transplant Proc1988https://conductscience.org/library/papers/2966477PubMed
172989408Sequential expression of genes involved in human T lymphocyte growth and differentiation.J Exp Med1985https://conductscience.org/library/papers/2989408PubMed
182935576Immunosuppressive effects of cyclosporin A on cloned T cells.J Immunol1986https://conductscience.org/library/papers/2935576PubMed
193129720T-cell-specific expression of interleukin 2: evidence for a negative regulatory site.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/3129720PubMed
203140380I kappa B: a specific inhibitor of the NF-kappa B transcription factor.Science1988https://conductscience.org/library/papers/3140380PubMed

See all 70 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.

PMIDTitleJournalYearIn PapersSource
42193179Tacrolimus (FK506) Attenuates Hepatic Ischemia-Reperfusion Injury via Oxidative Glutathione Metabolism and Suppression of Lipoxygenase-Mediated Cell Death.Antioxidants (Basel)2026https://conductscience.org/library/papers/42193179PubMed
35955565Low-Dose Tacrolimus Promotes the Migration and Invasion and Nitric Oxide Production in the Human-Derived First Trimester Extravillous Trophoblast Cells In Vitro.Int J Mol Sci2022https://conductscience.org/library/papers/35955565PubMed
32397400Endoplasmic Reticulum Calcium Pumps and Tumor Cell Differentiation.Int J Mol Sci2020https://conductscience.org/library/papers/32397400PubMed
31024070Low-Dose Tacrolimus Prevents Dysregulated Peri-Conceptional Ovarian and Systemic Immune Cellular Homeostasis in Subjects with PCOS.Sci Rep2019https://conductscience.org/library/papers/31024070PubMed
23497558
Protocol TOP-Study (tacrolimus organ perfusion): a prospective randomized multicenter trial to reduce ischemia reperfusion injury in transplantation of marginal liver grafts with an ex vivo tacrolimus perfusion.
Transplant Res2013https://conductscience.org/library/papers/23497558PubMed
21436963Tacrolimus ointment in the management of atopic dermatitis.Clin Cosmet Investig Dermatol2009https://conductscience.org/library/papers/21436963PubMed
8376940Identification of a novel cyclosporin-sensitive element in the human tumor necrosis factor alpha gene promoter.J Exp Med1993https://conductscience.org/library/papers/8376940PubMed
8234287Differential expression of four members of the POU family of proteins in activated and phorbol 12-myristate 13-acetate-treated Jurkat T cells.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/8234287PubMed
8029023Cyclosporin A sensitivity of the NF-kappa B site of the IL2R alpha promoter in untransformed murine T cells.Nucleic Acids Res1994https://conductscience.org/library/papers/8029023PubMed
7650486Activation and expression of the nuclear factors of activated T cells, NFATp and NFATc, in human natural killer cells: regulation upon CD16 ligand binding.J Exp Med1995https://conductscience.org/library/papers/7650486PubMed
7532676FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells.J Exp Med1995https://conductscience.org/library/papers/7532676PubMed
7506654Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.Drugs1993https://conductscience.org/library/papers/7506654PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene
IL2RA3559PubTator's text mininghttps://conductscience.org/library/genes/3559NCBI Gene
MT2A4502PubTator's text mininghttps://conductscience.org/library/genes/4502NCBI Gene
NFATC24773PubTator's text mininghttps://conductscience.org/library/genes/4773NCBI Gene
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1712901

GET https://conductscience.org/api/papers/v1/1712901/references?page=2